|
1
|
Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
|
PLoS Med
|
2006
|
5.80
|
|
2
|
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.
|
Cancer Cell
|
2002
|
3.12
|
|
3
|
The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection.
|
Genome Res
|
2004
|
2.54
|
|
4
|
A quantitative promoter methylation profile of prostate cancer.
|
Clin Cancer Res
|
2004
|
2.06
|
|
5
|
Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker.
|
Clin Cancer Res
|
2004
|
1.76
|
|
6
|
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
|
Clin Cancer Res
|
2008
|
1.62
|
|
7
|
High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.
|
Clin Cancer Res
|
2007
|
1.30
|
|
8
|
KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
|
Int J Cancer
|
2010
|
1.26
|
|
9
|
Assessment of gene promoter hypermethylation for detection of cervical neoplasia.
|
Int J Cancer
|
2006
|
1.23
|
|
10
|
Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR.
|
Clin Cancer Res
|
2010
|
1.18
|
|
11
|
MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.18
|
|
12
|
Absence of V599E BRAF mutations in desmoplastic melanomas.
|
Cancer
|
2005
|
1.17
|
|
13
|
Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma.
|
Clin Cancer Res
|
2011
|
1.09
|
|
14
|
Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
|
Mol Cancer Res
|
2006
|
1.09
|
|
15
|
Immunohistochemical p53 expression patterns in sarcomatoid carcinomas of the upper respiratory tract.
|
Am J Surg Pathol
|
2002
|
1.09
|
|
16
|
A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma.
|
Int J Cancer
|
2011
|
1.08
|
|
17
|
Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
|
Clin Cancer Res
|
2011
|
1.04
|
|
18
|
LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer.
|
Cancer Res
|
2006
|
1.03
|
|
19
|
Performance of mitochondrial DNA mutations detecting early stage cancer.
|
BMC Cancer
|
2008
|
1.02
|
|
20
|
Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.
|
Breast Cancer Res Treat
|
2007
|
0.99
|
|
21
|
Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.
|
Cell Cycle
|
2013
|
0.96
|
|
22
|
Oxidized guanine lesions and hOgg1 activity in lung cancer.
|
Oncogene
|
2005
|
0.96
|
|
23
|
Quantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumors.
|
PLoS One
|
2010
|
0.95
|
|
24
|
Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
|
DNA Cell Biol
|
2005
|
0.93
|
|
25
|
Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection.
|
PLoS One
|
2013
|
0.92
|
|
26
|
Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer.
|
Epigenetics
|
2012
|
0.90
|
|
27
|
Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.
|
PLoS One
|
2013
|
0.90
|
|
28
|
Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
|
Laryngoscope
|
2007
|
0.84
|
|
29
|
Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.
|
Oncotarget
|
2014
|
0.83
|
|
30
|
AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy.
|
Prostate
|
2011
|
0.83
|
|
31
|
Genome-wide analysis of genetic alterations in testicular primary seminoma using high resolution single nucleotide polymorphism arrays.
|
Genomics
|
2011
|
0.82
|
|
32
|
AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer.
|
Tumour Biol
|
2011
|
0.82
|
|
33
|
Presence of 5-methylcytosine in CpNpG trinucleotides in the human genome.
|
Genomics
|
2010
|
0.81
|
|
34
|
Overexpression of p27(Kip1) induces growth arrest and apoptosis in an oral cancer cell line.
|
Oral Oncol
|
2002
|
0.81
|
|
35
|
Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection.
|
Histopathology
|
2015
|
0.80
|
|
36
|
Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
|
Int J Oncol
|
2003
|
0.77
|